We support the development of producer cell lines and optimize the viral vector platform for your product. We ensure your process is robust, scalable, and transferable from early phase through to commercial production to simplify your regulatory strategy.
Our team guides and optimizes your viral vector production process, ensuring it is repeatable, scalable, and transferable to cGMP manufacturing. We work with you to ensure efficient scale-up, increase titers, reduce development timelines, and lower costs as we support your upstream and downstream process development.
We offer flexible manufacturing capacity and support scale-up for both adherent and suspension platforms. Whether you need to adapt and develop a suspension process or scale an adherent process from research to clinical-grade production, everything we do is meaningfully focused on getting your viral vector to commercialization.
Ensuring quality and efficiency, we develop reproducible, scalable and robust processes in closed systems which also help minimize to opportunities for errors.
We accelerate your program with in-house analytical assay development and qualification tailored to your vector and/or gene of interest.
Unique expertise in GMP lentiviral and retroviral vector manufacturing, paired with a new state-of-the-art facility, we have the capacity and know-how to support your manufacturing needs.Read more
Leverage our world-class partnerships, streamline your production, and advance your cell therapy to trial and beyond.Read more